Skip to content

Study of the effects of adding remifentanil to anesthetic drugs before succinylcholine on post operative myalgia

Study of pretreatment effects of remifentanil on succinylcholine-induced fasciculation and post operative pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138712241766N1
Enrollment
60
Registered
2009-09-11
Start date
2008-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: post operative pain. Condition 2: Skeletal muscle relaxants. Myalgia Skeletal muscle relaxants [neuromuscular blocking agents]

Interventions

Intervention 1: Remifentanil: in remifentanil group induction regimen is as follow: At time 0, injection of fentanyl 1 µg/kg and pretreatment (remifentanil 1µg/kg that be adjusted to a 3-mL volume) 2
Treatment - Drugs
Placebo
Remifentanil: in remifentanil group induction regimen is as follow: At time 0, injection of fentanyl 1 µg/kg and pretreatment (remifentanil 1µg/kg that be adjusted to a 3-mL volume) 2 min later, then
0.9 saline normal: In saline group induction regimen is as follow: At time 0, injection of fentanyl 1 µg/kg and pretreatment ( 3 ML 0.9 saline normal) 2 min later, then propofol 2 mg/kg and after loss

Sponsors

Kurdistan university of medical siences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I or II, ambulatory urological or gynecological surgery under general anesthesia. Exclusion criteria : arrhythmia, hypo- or hypertension, hyperkalemia, increased intraocular pressure, increased intracranial pressure, presenting a difficult airway, pregnant, treatment with any drug known to interact with neuromuscular function, and significant renal, neuromuscular, or hepatic disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Muscle fasciculation. Timepoint: after adminstration of succinylcoline. Method of measurement: Observational by 4-point scale: no fasciculation= 0; mild, fine fasciculation of the eyes, neck, face or fingers without limb movement = 1; moderate fasciculation occurring at more than two sites or obvious limb movement = 2; vigorous or severe, sustained, and widespread fasciculation = 3.;Post operative pain. Timepoint: 1 ,6 and 24 hours after operation. Method of measurement: 4-point scale: nil = no muscle pains or stiffness; mild = muscle pains or stiffness at one site but not causing disability or limiting activities; moderate = muscle pains or stiffness at more than one site but not causing disability or limiting activities; severe = muscle pains or stiffness at one site or more and causing disability or limiting activities, e.g., difficulty getting out of bed or turning the head.

Secondary

MeasureTime frame
Blood pressure changes. Timepoint: before induction of anesthesia and after ending fasciculation. Method of measurement: automated oscilometer.;Heart rate changes. Timepoint: Before induction of anesthesia and after ending fasciculation. Method of measurement: BSI (passport2) automated monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Tayebi Arasteh

Faculty of medicine

mehtayeb@gmail.com+98 87 1666 6463

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026